IDEXX Laboratories

YTD

ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacturing, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing industries. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other.

CEO

Michael Erickson

CEOMichael Erickson

Employees

11,000

Employees11,000

Headquarters

Westbrook, Maine

HeadquartersWestbrook, Maine

Founded

1983

Founded1983

Employees

11,000

Employees11,000

IDXX Key Statistics

Market cap

42.99B

Market cap42.99B

Price-Earnings ratio

39.51

Price-Earnings ratio39.51

Dividend yield

—

Dividend yield—

Average volume

556.32K

Average volume556.32K

High today

$563.13

High today$563.13

Low today

$543.60

Low today$543.60

Open price

$561.55

Open price$561.55

Volume

584.99K

Volume584.99K

52 Week high

$769.98

52 Week high$769.98

52 Week low

$518.55

52 Week low$518.55

Stock Snapshot

As of today, IDEXX Laboratories(IDXX) shares are valued at $545.31. The company's market cap stands at 42.99B, with a P/E ratio of 39.51.

On 2026-08-20, IDEXX Laboratories(IDXX) stock moved within a range of $543.60 to $563.13. With shares now at $545.31, the stock is trading +0.3% above its intraday low and -3.2% below the session's peak.

Trading volume for IDEXX Laboratories(IDXX) stock has reached 584.99K, versus its average volume of 556.32K.

The stock's 52-week range extends from a low of $518.55 to a high of $769.98.

IDXX News

Simply Wall St 18h

Will In-Clinic Cardiac Testing Expansion via Catalyst proBNP Test Change IDEXX Laboratories' Narrative

IDEXX Laboratories has launched the Catalyst proBNP Test, the first dual-species in-clinic NT-proBNP cardiac assay for cats and dogs, extending its connected di...

Simply Wall St 2d

IDEXX Laboratories Could Be 22% Undervalued As New Cardiac Test Expands Its Reach

Advertisement New cardiac test launch puts IDEXX Laboratories stock in focus IDEXX Laboratories (IDXX) has drawn fresh investor attention after announcing the...

Nasdaq 6d

IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests

IDEXX Laboratories (NASDAQ:IDXX) outlined an innovation-led growth strategy at its 2026 Investor Day, highlighting a $45 billion global companion-animal testing...

Analyst ratings

56%

of 16 ratings

Buy

56.3%

Hold

37.5%

Sell

6.3%

More IDXX News

TipRanks 6d

Idexx: Neutral Stance Maintained as Long-Term Outlook Stays Opaque, Target Price Raised to $665

In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Idexx Laboratories, with a price target of $665.00. Unlo...

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.